A. Albada, S. Van-dulmen, D. Lindhout, J. M. Bensing, and M. G. Ausems, A pre-visit tailored website enhances counselees' realistic expectations and knowledge and fulfils information needs for breast cancer genetic counselling, Familial Cancer, vol.11, issue.1, pp.85-95, 2012.

M. V. Báguena, M. Beleña, A. &. Martinez, C. Roldan, and R. Reig, , 2001.

, Psychometric properties of the Spanish version of the Impact of Event Scale-Revised (IES-R), vol.27, pp.581-604

P. Bennett, C. Phelps, J. Hilgart, K. Hood, K. Brain et al., Concerns and coping during cancer genetic risk assessment, Psycho-Oncology, vol.21, issue.6, pp.611-617, 2012.

A. R. Bradbury, L. J. Patrick-miller, B. L. Egleston, M. J. Hall, S. M. Domchek et al., Randomized Noninferiority Trial of Telephone vs In-Person Disclosure of Germline Cancer Genetic Test Results, Journal of the National Cancer Institute, vol.110, issue.9, pp.985-993, 2018.

A. Brédart, J. L. Kop, A. C. Griesser, C. Fiszer, K. Zaman et al.,

S. Dolbeault, Assessment of needs, health-related quality of life, and satisfaction with care in breast cancer patients to better target supportive care, Annals of Oncology, vol.24, issue.8, pp.2151-2158, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01583937

A. Brunet, A. St-hilaire, L. Jehel, and S. King, Validation of a French version of the impact of event scale-revised, Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, vol.48, issue.1, pp.56-61, 2003.

D. Cella, C. Hughes, A. Peterman, C. Chang, B. N. Peshkin et al., A brief assessment of concerns associated with genetic testing for cancer: The multidimensional impact of cancer risk assessment (MICRA) questionnaire, Health Psychology, vol.21, issue.6, pp.564-572, 2002.

J. Cohen, Statistical power analysis for the behavioural sciences, 1988.

F. J. Couch, K. L. Nathanson, and K. Offit, Two decades after BRCA: setting paradigms in personalized cancer care and prevention, Science, vol.343, issue.6178, pp.1466-1470, 2014.

L. J. Cronbach and W. G. Warrington, Time-limit tests: estimating their reliability and degree of speeding, Psychometrika, vol.16, issue.2, pp.167-188, 1951.

S. M. Domchek, A. Bradbury, J. E. Garber, K. Offit, and M. E. Robson, Multiplex genetic testing for cancer susceptibility: out on the high wire without a net, Journal of Clinical Oncology, vol.31, issue.10, 2013.

W. Eijzenga, N. K. Aaronson, D. E. Hahn, G. N. Sidharta, L. E. Van-der-kolk et al.,

E. M. Bleiker, Effect of Routine Assessment of Specific Psychosocial Problems on Personalized Communication, Counselors' Awareness, and Distress Levels in Cancer Genetic Counseling Practice: A Randomized Controlled Trial, Journal of Clinical Oncology, vol.2, issue.27, pp.2998-3004, 2014.

W. Eijzenga, E. M. Bleiker, D. E. Hahn, I. Kluijt, G. N. Sidharta et al., , 2014.

, Psychosocial Aspects of Hereditary Cancer (PAHC) questionnaire: development and testing of a screening questionnaire for use in clinical cancer genetics, Psycho-Oncology, vol.23, issue.8, pp.862-869

W. Eijzenga, E. M. Bleiker, D. E. Hahn, L. E. Van-der-kolk, G. N. Sidharta et al., Prevalence and detection of psychosocial problems in cancer genetic counseling, Familial Cancer, vol.14, issue.4, pp.629-636, 2015.

I. Esteban, M. Vilaro, E. Adrover, N. Angulo, E. Carrasco et al.,

J. Balmana, Psychological impact of multi-gene cancer panel testing in patients with a clinical suspicion of hereditary cancer across Spain, Psycho-Oncology, vol.27, issue.6, pp.1530-1537, 2018.

A. Farrelly, V. White, B. Meiser, M. Jefford, M. A. Young et al., Unmet support needs and distress among women with a BRCA1/2 mutation, Familial Cancer, vol.12, issue.3, pp.509-518, 2013.

M. J. Herrero, J. Blanch, J. M. Peri, J. De-pablo, L. Pintor et al., A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population, General Hospital Psychiatry, vol.25, issue.4, pp.277-283, 2003.

J. G. Hamilton, M. Lobel, and A. Moyer, Emotional distress following genetic testing for hereditary breast and ovarian cancer: a meta-analytic review, Health Psychology, vol.28, issue.4, pp.510-518, 2009.

S. Hiraki, E. S. Rinella, F. Schnabel, R. Oratz, and H. Ostrer, Cancer risk assessment using genetic panel testing: considerations for clinical application, J Genet Couns, vol.23, issue.4, pp.604-617, 2014.

D. L. Jackson, J. A. Gillaspy, and R. Purc-stephenson, Reporting practices in confirmatory factor analysis: an overview and some recommendations, Psychological Methods, vol.14, issue.1, pp.6-23, 2009.

R. Jaeschke, J. Singer, and G. H. Guyatt, Measurement of health status. Ascertaining the minimal clinically important difference, Controlled Clinical Trials, vol.10, issue.4, pp.407-415, 1989.

C. Johnson, J. M. Blazeby, A. Bottomley, P. Fayers, K. Koller et al.,

, Group Guidelines for developing questionnaire modules

D. Kuli?, A. Bottomley, G. Velikova, E. Greimel, and M. Koller, on behalf of the EORTC Quality of Life Group, 2017.

A. J. Lee, A. P. Cunningham, K. B. Kuchenbaecker, N. Mavaddat, D. F. Easton et al., BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface, British Journal of Cancer, vol.110, issue.2, pp.535-545, 2014.

H. S. Lumish, H. Steinfeld, C. Koval, D. Russo, E. Levinson et al., Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients, J Genet Couns, vol.26, issue.5, pp.1116-1129, 2017.

J. Maringwa, C. Quinten, M. King, J. Ringash, D. Osoba et al., Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients, Annals of Oncology, vol.22, issue.9, pp.2107-2112, 2011.

L. B. Mokkink, C. Terwee, D. L. Patrick, J. Alonso, P. W. Stratford et al., Cosmin checklist manual, 2010.

A. Oberguggenberger, M. Sztankay, R. J. Morscher, B. Sperner-unterweger, I. Weber et al.,

V. Meraner, Psychosocial outcomes and counselee satisfaction following genetic counseling for hereditary breast and ovarian cancer: A patient-reported outcome study, Journal of Psychosomatic Research, vol.89, pp.39-45, 2016.

A. H. Pieterse, M. G. Ausems, A. M. Van-dulmen, F. A. Beemer, and J. M. Bensing, Initial cancer genetic counseling consultation: change in counselees' cognitions and anxiety, and association with addressing their needs and preferences, American Journal of Medical Genetics. Part A, vol.137, issue.1, pp.27-35, 2005.

A. H. Pieterse, A. M. Van-dulmen, F. A. Beemer, J. M. Bensing, and M. G. Ausems, Cancer genetic counseling: communication and counselees' post-visit satisfaction, cognitions, anxiety, and needs fulfillment, J Genet Couns, vol.16, issue.1, pp.85-96, 2007.

D. Razavi, N. Delvaux, C. Farvacques, and E. Robaye, Screening for adjustment disorders and major depressive disorders in cancer in-patients, British Journal of Psychiatry, vol.156, pp.79-83, 1990.

D. Revicki, R. D. Hays, D. Cella, and J. Sloan, Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes, J Clin Epidemiol, vol.61, pp.102-109, 2008.

K. S. Sun, T. P. Lam, K. F. Lam, T. L. Lo, D. V. Chao et al., Enablers to seeking professional help for psychological distress-a study on Chinese primary care attenders, Psychiatry Research, vol.264, pp.9-14, 2018.

A. Taylor, A. F. Brady, I. M. Frayling, H. Hanson, M. Tischkowitz et al.,

U. K. Group, Consensus for genes to be included on cancer panel tests offered by UK genetics services: guidelines of the UK Cancer Genetics Group, Journal of Medical Genetics, vol.55, issue.6, pp.372-377, 2018.

M. S. Van-roosmalen, P. F. Stalmeier, L. C. Verhoef, J. E. Hoekstra-weebers, J. C. Oosterwijk et al., Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation, British Journal of Cancer, vol.90, issue.2, pp.333-342, 2004.

D. S. Weiss and C. R. Marmar, Assessing psychological trauma and PTSD, pp.399-411, 1997.